14 results on '"Shinya Shimoyama"'
Search Results
2. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020)
- Author
-
Moritoki Egi, Hiroshi Ogura, Tomoaki Yatabe, Kazuaki Atagi, Shigeaki Inoue, Toshiaki Iba, Yasuyuki Kakihana, Tatsuya Kawasaki, Shigeki Kushimoto, Yasuhiro Kuroda, Joji Kotani, Nobuaki Shime, Takumi Taniguchi, Ryosuke Tsuruta, Kent Doi, Matsuyuki Doi, Taka-aki Nakada, Masaki Nakane, Seitaro Fujishima, Naoto Hosokawa, Yoshiki Masuda, Asako Matsushima, Naoyuki Matsuda, Kazuma Yamakawa, Yoshitaka Hara, Masaaki Sakuraya, Shinichiro Ohshimo, Yoshitaka Aoki, Mai Inada, Yutaka Umemura, Yusuke Kawai, Yutaka Kondo, Hiroki Saito, Shunsuke Taito, Chikashi Takeda, Takero Terayama, Hideo Tohira, Hideki Hashimoto, Kei Hayashida, Toru Hifumi, Tomoya Hirose, Tatsuma Fukuda, Tomoko Fujii, Shinya Miura, Hideto Yasuda, Toshikazu Abe, Kohkichi Andoh, Yuki Iida, Tadashi Ishihara, Kentaro Ide, Kenta Ito, Yusuke Ito, Yu Inata, Akemi Utsunomiya, Takeshi Unoki, Koji Endo, Akira Ouchi, Masayuki Ozaki, Satoshi Ono, Morihiro Katsura, Atsushi Kawaguchi, Yusuke Kawamura, Daisuke Kudo, Kenji Kubo, Kiyoyasu Kurahashi, Hideaki Sakuramoto, Akira Shimoyama, Takeshi Suzuki, Shusuke Sekine, Motohiro Sekino, Nozomi Takahashi, Sei Takahashi, Hiroshi Takahashi, Takashi Tagami, Goro Tajima, Hiroomi Tatsumi, Masanori Tani, Asuka Tsuchiya, Yusuke Tsutsumi, Takaki Naito, Masaharu Nagae, Ichiro Nagasawa, Kensuke Nakamura, Tetsuro Nishimura, Shin Nunomiya, Yasuhiro Norisue, Satoru Hashimoto, Daisuke Hasegawa, Junji Hatakeyama, Naoki Hara, Naoki Higashibeppu, Nana Furushima, Hirotaka Furusono, Yujiro Matsuishi, Tasuku Matsuyama, Yusuke Minematsu, Ryoichi Miyashita, Yuji Miyatake, Megumi Moriyasu, Toru Yamada, Hiroyuki Yamada, Ryo Yamamoto, Takeshi Yoshida, Yuhei Yoshida, Jumpei Yoshimura, Ryuichi Yotsumoto, Hiroshi Yonekura, Takeshi Wada, Eizo Watanabe, Makoto Aoki, Hideki Asai, Takakuni Abe, Yutaka Igarashi, Naoya Iguchi, Masami Ishikawa, Go Ishimaru, Shutaro Isokawa, Ryuta Itakura, Hisashi Imahase, Haruki Imura, Takashi Irinoda, Kenji Uehara, Noritaka Ushio, Takeshi Umegaki, Yuko Egawa, Yuki Enomoto, Kohei Ota, Yoshifumi Ohchi, Takanori Ohno, Hiroyuki Ohbe, Kazuyuki Oka, Nobunaga Okada, Yohei Okada, Hiromu Okano, Jun Okamoto, Hiroshi Okuda, Takayuki Ogura, Yu Onodera, Yuhta Oyama, Motoshi Kainuma, Eisuke Kako, Masahiro Kashiura, Hiromi Kato, Akihiro Kanaya, Tadashi Kaneko, Keita Kanehata, Ken-ichi Kano, Hiroyuki Kawano, Kazuya Kikutani, Hitoshi Kikuchi, Takahiro Kido, Sho Kimura, Hiroyuki Koami, Daisuke Kobashi, Iwao Saiki, Masahito Sakai, Ayaka Sakamoto, Tetsuya Sato, Yasuhiro Shiga, Manabu Shimoto, Shinya Shimoyama, Tomohisa Shoko, Yoh Sugawara, Atsunori Sugita, Satoshi Suzuki, Yuji Suzuki, Tomohiro Suhara, Kenji Sonota, Shuhei Takauji, Kohei Takashima, Sho Takahashi, Yoko Takahashi, Jun Takeshita, Yuuki Tanaka, Akihito Tampo, Taichiro Tsunoyama, Kenichi Tetsuhara, Kentaro Tokunaga, Yoshihiro Tomioka, Kentaro Tomita, Naoki Tominaga, Mitsunobu Toyosaki, Yukitoshi Toyoda, Hiromichi Naito, Isao Nagata, Tadashi Nagato, Yoshimi Nakamura, Yuki Nakamori, Isao Nahara, Hiromu Naraba, Chihiro Narita, Norihiro Nishioka, Tomoya Nishimura, Kei Nishiyama, Tomohisa Nomura, Taiki Haga, Yoshihiro Hagiwara, Katsuhiko Hashimoto, Takeshi Hatachi, Toshiaki Hamasaki, Takuya Hayashi, Minoru Hayashi, Atsuki Hayamizu, Go Haraguchi, Yohei Hirano, Ryo Fujii, Motoki Fujita, Naoyuki Fujimura, Hiraku Funakoshi, Masahito Horiguchi, Jun Maki, Naohisa Masunaga, Yosuke Matsumura, Takuya Mayumi, Keisuke Minami, Yuya Miyazaki, Kazuyuki Miyamoto, Teppei Murata, Machi Yanai, Takao Yano, Kohei Yamada, Naoki Yamada, Tomonori Yamamoto, Shodai Yoshihiro, Hiroshi Tanaka, and Osamu Nishida
- Subjects
Evidence-based medicine ,GRADE ,Guidelines ,Sepsis ,Septic shock ,Systematic review ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
Abstract The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis and septic shock created as revised from J-SSCG 2016 jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in September 2020 and published in February 2021. An English-language version of these guidelines was created based on the contents of the original Japanese-language version. The purpose of this guideline is to assist medical staff in making appropriate decisions to improve the prognosis of patients undergoing treatment for sepsis and septic shock. We aimed to provide high-quality guidelines that are easy to use and understand for specialists, general clinicians, and multidisciplinary medical professionals. J-SSCG 2016 took up new subjects that were not present in SSCG 2016 (e.g., ICU-acquired weakness [ICU-AW], post-intensive care syndrome [PICS], and body temperature management). The J-SSCG 2020 covered a total of 22 areas with four additional new areas (patient- and family-centered care, sepsis treatment system, neuro-intensive treatment, and stress ulcers). A total of 118 important clinical issues (clinical questions, CQs) were extracted regardless of the presence or absence of evidence. These CQs also include those that have been given particular focus within Japan. This is a large-scale guideline covering multiple fields; thus, in addition to the 25 committee members, we had the participation and support of a total of 226 members who are professionals (physicians, nurses, physiotherapists, clinical engineers, and pharmacists) and medical workers with a history of sepsis or critical illness. The GRADE method was adopted for making recommendations, and the modified Delphi method was used to determine recommendations by voting from all committee members. As a result, 79 GRADE-based recommendations, 5 Good Practice Statements (GPS), 18 expert consensuses, 27 answers to background questions (BQs), and summaries of definitions and diagnosis of sepsis were created as responses to 118 CQs. We also incorporated visual information for each CQ according to the time course of treatment, and we will also distribute this as an app. The J-SSCG 2020 is expected to be widely used as a useful bedside guideline in the field of sepsis treatment both in Japan and overseas involving multiple disciplines.
- Published
- 2021
- Full Text
- View/download PDF
3. Physical Restraints in Critically Ill Children: A Multicenter Longitudinal Point Prevalence Study*
- Author
-
Yujiro Matsuishi, Atsushi Kawaguchi, Naoki Fujiwara, Takehiro Nittsu, Emi Sasaki, Muneyuki Takeuchi, Chisato Akita, Ryo Ikebe, Ikkei Munekawa, Katsuko Sakamoto, Wakato Matsuoka, Yumi Kajinishi, Shinya Shimoyama, Tatsuya Kawasaki, Norimasa Miura, and Yuko Nakayama
- Subjects
Male ,Restraint, Physical ,medicine.medical_specialty ,Critical Illness ,Prevalence ,MEDLINE ,Child Welfare ,Intensive Care Units, Pediatric ,Critical Care and Intensive Care Medicine ,Odds ,Japan ,Patient age ,medicine ,Humans ,In patient ,Longitudinal Studies ,Child ,Critically ill ,business.industry ,Infant ,Physical restraints ,Frequent use ,Child, Preschool ,Emergency medicine ,business - Abstract
Objectives We elucidate to investigate the prevalence of and factors associated with the use of physical restraints among critically ill or injured children in PICUs. Design This was a multicenter, longitudinal point prevalence study. Setting We included 26 PICUs in Japan. Patients Included children were 1 month to 10 years old. We screened all admitted patients in the PICUs on three study dates (in March, June, and September 2019). Intervention None. Measurements and main results We collected prevalence and demographic characteristics of critically ill or injured children with physical restraints, as well as details of physical restraints, including indications and treatments provided. A total of 398 children were screened in the participating PICUs on the three data collection dates. The prevalence of children with physical restraints was 53% (211/398). Wrist restraint bands were the most frequently used means (55%, 117/211) for potential contingent events. The adjusted odds of using physical restraint in patients 1-2 years old was 2.3 (95% CI, 1.3-4.0) compared with children less than 1 year old. When looking at the individual hospital effect, units without a prespecified practice policy for physical restraints management or those with more than 10 beds were more likely to use physical restraints. Conclusions The prevalence of physical restraints in critically ill or injured children was high, and significant variation was observed among PICUs. Our study findings suggested that patient age, unit size, and practice policy of physical restraint could be associated with more frequent use of physical restraints.
- Published
- 2021
- Full Text
- View/download PDF
4. A large amount of microscopic precipitates are inevitably injected during infusion therapy without an in-line filter
- Author
-
Shinya Shimoyama, Daisuke Takahashi, Syuhei Arai, Yuji Asami, Kimiko Nakajima, Kentaro Ikeda, Takumi Takizawa, and Tomio Kobayashi
- Subjects
Infectious Diseases ,Parasitology ,Microbiology - Abstract
Infusion route problems can have a significant impact on hemodynamics in children with severe heart failure. Here, we report the case of a 13-year-old girl with dilated cardiomyopathy. Her condition fluctuated due to frequent occlusion of the central venous catheter (CVC) route. However, a quick check revealed no apparent abnormalities in the CVC, infusion route, in-line filter or infusion pump. Scanning electron microscopy revealed that dobutamine and heparin had crystallized and that the in-line filter membrane was occluded. This case emphasizes the importance of proper infusion route management in pediatric patients with severe heart failure. Even drugs that are used daily may form microscopic crystals at several concentrations and administration rates. Without an in-line filter, microscopic particles are injected into the body, and there is no evidence that the injected crystals do not cause permanent damage.
- Published
- 2022
- Full Text
- View/download PDF
5. Visual liver assessment using Gd-EOB-DTPA–enhanced magnetic resonance imaging of patients in the early post-Fontan period
- Author
-
Kensuke Tanaka, Yasunori Okada, Takashi Miyamoto, Shuhei Arai, Mitsuru Seki, Kentaro Ikeda, Takumi Takizawa, Shinitsu Hatakeyama, Kimiko Nakajima, Takashi Kobayashi, Hirokazu Arakawa, Yuji Asami, and Shinya Shimoyama
- Subjects
Male ,medicine.medical_treatment ,lcsh:Medicine ,Gadolinium ,02 engineering and technology ,030204 cardiovascular system & hematology ,Inferior vena cava ,Article ,Fontan procedure ,03 medical and health sciences ,Liver disease ,0302 clinical medicine ,Fibrosis ,medicine ,Humans ,lcsh:Science ,Child ,Cardiac catheterization ,Retrospective Studies ,Multidisciplinary ,medicine.diagnostic_test ,business.industry ,Liver Diseases ,lcsh:R ,Magnetic resonance imaging ,Retrospective cohort study ,Diagnostic markers ,Pentetic Acid ,021001 nanoscience & nanotechnology ,medicine.disease ,Magnetic Resonance Imaging ,medicine.anatomical_structure ,medicine.vein ,Congenital heart defects ,Child, Preschool ,Vascular resistance ,lcsh:Q ,Female ,0210 nano-technology ,Nuclear medicine ,business - Abstract
No imaging modality can be used to evaluate Fontan-associated liver disease (FALD). We retrospectively reviewed hepatic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) characteristics of patients within 1 year post-Fontan procedure, and we evaluated the association between hepatic imaging abnormalities and clinical parameters, including follow-up cardiac catheterization and laboratory test findings. The EOB-MR images were graded, based on the extent of the decreased enhancement, as “normal” (Grade 1), “segmental” (Grade 2), “regional” (Grade 3), and “diffuse” (Grade 4). We enrolled 37 patients (mean age, 3.5 ± 1.0 years): 9 patients had Grade 1 or 2; 14 patients, Grade 3; and 14 patients, Grade 4. EOB-MRI revealed characteristic reticular or mosaic patterns of diminished enhancement (i.e. “frog spawn” appearance). Ultrasonography did not detect diminished enhancement or “frog spawn” appearance. A trend existed toward increased grade severity in imaging with increased central venous pressure, pulmonary vascular resistance, and gamma-glutamyltransferase levels. Noninvasive EOB-MRI revealed the characteristic pattern of diminished enhancement, which was correlated with certain clinical parameters indicative of Fontan physiology and liver dysfunction. Early-stage FALD may occur soon after the Fontan procedure and is associated with increased pressure in the inferior vena cava and hepatic veins.
- Published
- 2020
6. Dietary protein restriction throughout intrauterine and postnatal life results in potentially beneficial myocardial tissue remodeling in the adult mouse heart
- Author
-
Maria, Hennig, Lea, Ewering, Simon, Pyschny, Shinya, Shimoyama, Maja, Olecka, Dominik, Ewald, Manuela, Magarin, Anselm, Uebing, Ludwig, Thierfelder, Christian, Jux, and Jörg-Detlef, Drenckhahn
- Subjects
Male ,Vascular Endothelial Growth Factor A ,Aging ,Heart Ventricles ,Neovascularization, Physiologic ,lcsh:Medicine ,Cell Count ,Article ,Heart development ,Mice ,Pregnancy ,hemic and lymphatic diseases ,Diet, Protein-Restricted ,Animals ,Myocytes, Cardiac ,Amino Acids ,lcsh:Science ,Cell Proliferation ,Cell Size ,Sex Characteristics ,Body Weight ,lcsh:R ,Heart ,Feeding Behavior ,Organ Size ,Intrauterine growth ,Capillaries ,Mice, Inbred C57BL ,Cardiac hypertrophy ,Animals, Newborn ,Cardiovascular and Metabolic Diseases ,Female ,lcsh:Q ,Signal Transduction - Abstract
Diet composition impacts metabolic and cardiovascular health with high caloric diets contributing to obesity related disorders. Dietary interventions such as caloric restriction exert beneficial effects in the cardiovascular system, but alteration of which specific nutrient is responsible is less clear. This study investigates the effects of a low protein diet (LPD) on morphology, tissue composition and function of the neonatal and adult mouse heart. Mice were subjected to LPD (8.8% protein) or standard protein diet (SPD, 22% protein) throughout intrauterine and postnatal life. At birth LPD female but not male offspring exhibit reduced body weight whereas heart weight was unchanged in both sexes. Cardiomyocyte cross sectional area was increased in newborn LPD females compared to SPD, whereas proliferation, cellular tissue composition and vascularization were unaffected. Adult female mice on LPD exhibit reduced body weight but normal heart weight compared to SPD controls. Echocardiography revealed normal left ventricular contractility in LPD animals. Histology showed reduced interstitial fibrosis, lower cardiomyocyte volume and elevated numbers of cardiomyocyte and non-myocyte nuclei per tissue area in adult LPD versus SPD myocardium. Furthermore, capillary density was increased in LPD hearts. In conclusion, pre- and postnatal dietary protein restriction in mice causes a potentially beneficial myocardial remodeling.
- Published
- 2019
7. A large superior mesenteric artery aneurysm and ileal obstruction: a rare presentation of polyarteritis nodosa in an infant
- Author
-
Tomoyuki Imagawa, Shinya Shimoyama, Yoshiyuki Yamada, Akihiko Shimizu, Shinya Takazawa, Akira Nishi, Takashi Kobayashi, Junko Hirato, and Kensuke Tanaka
- Subjects
030203 arthritis & rheumatology ,medicine.medical_specialty ,Polyarteritis nodosa ,business.industry ,medicine.medical_treatment ,Case Report ,Bowel resection ,030204 cardiovascular system & hematology ,medicine.disease ,Microbiology ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,Infectious Diseases ,Aneurysm ,medicine.anatomical_structure ,Prednisolone ,medicine ,Parasitology ,Ileal Obstruction ,Arteritis ,Vasculitis ,business ,medicine.drug ,Artery - Abstract
Polyarteritis nodosa (PAN) is a rare form of vasculitis that occurs in childhood and affects small- and medium-sized arteries. Large aneurysms due to PAN can induce fatal complications like rupturing or occlusion of the affected arteries. Here, we report a case of a 4-month-old girl with PAN complicated by a large superior mesenteric artery aneurysm and ileal obstruction. We controlled her blood pressure to prevent the artery from rupturing. A combination of prednisolone, intravenous cyclophosphamide, and plasma exchange reduced the inflammation. She developed mechanical ileus due to ileum stricture and underwent bowel resection. Histopathological examinations revealed reparative arteritis around the healed ulcer. Her postoperative course was uneventful without further dilatation of the aneurysm. This case highlights the importance of intensive immunosuppressive therapy and appropriate blood pressure control in pediatric patients with PAN complicated by large aneurysms. Mechanical ileus can develop and may require surgical management even after remission of vasculitis.
- Published
- 2019
8. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020)
- Author
-
Kazuma Yamakawa, Takeshi Unoki, Yoh Sugawara, Hiroyuki Kawano, Ayaka Sakamoto, Kenji Uehara, Yasuyuki Kakihana, Eizo Watanabe, Hiromu Okano, Yukitoshi Toyoda, Goro Tajima, Ryuichi Yotsumoto, Hiroshi Ogura, Asako Matsushima, Motoshi Kainuma, Ryo Fujii, Takuya Mayumi, Tomonori Yamamoto, Masaaki Sakuraya, Yuuki Tanaka, Toshikazu Abe, Tomoko Fujii, Daisuke Kobashi, Naoki Yamada, Yoshiki Masuda, Satoru Hashimoto, Atsunori Sugita, Kazuaki Atagi, Yutaka Igarashi, Akira Shimoyama, Tomohisa Nomura, Tasuku Matsuyama, Jun Maki, Akemi Utsunomiya, Kazuya Kikutani, Kei Nishiyama, Joji Kotani, Megumi Moriyasu, Yasuhiro Kuroda, Hiromi Kato, Ryuta Itakura, Seitaro Fujishima, Yusuke Kawamura, Kazuyuki Oka, Hiroyuki Koami, Asuka Tsuchiya, Jun Okamoto, Yasuhiro Shiga, Hiroki Saito, Masaharu Nagae, Hiroyuki Ohbe, Kenji Sonota, Kentaro Tomita, Yutaka Kondo, Sho Kimura, Haruki Imura, Taiki Haga, Satoshi Ono, Tomoaki Yatabe, Yuki Enomoto, Yohei Hirano, Yuji Suzuki, Jun Takeshita, Kentaro Ide, Junji Hatakeyama, Kazuyuki Miyamoto, Naoki Tominaga, Masanori Tani, Hideo Tohira, Yuhta Oyama, Toru Hifumi, Yuji Miyatake, Kohei Yamada, Yoshimi Nakamura, Hiromu Naraba, Hideki Asai, Daisuke Kudo, Mitsunobu Toyosaki, Yuhei Yoshida, Takaki Naito, Hideaki Sakuramoto, Naoto Hosokawa, Takao Yano, Shutaro Isokawa, Hiroshi Yonekura, Masaki Nakane, Shusuke Sekine, Hiroshi Takahashi, Atsuki Hayamizu, Masami Ishikawa, Ryo Yamamoto, Tomoya Nishimura, Iwao Saiki, Hiromichi Naito, Go Haraguchi, Kenichi Tetsuhara, Hideki Hashimoto, Toru Yamada, Yosuke Matsumura, Yuko Egawa, Daisuke Hasegawa, Noritaka Ushio, Takanori Ohno, Teppei Murata, Mai Inada, Osamu Nishida, Motoki Fujita, Masahito Horiguchi, Jumpei Yoshimura, Nobunaga Okada, Hitoshi Kikuchi, Nana Furushima, Koji Endo, Yasuhiro Norisue, Yuya Miyazaki, Chikashi Takeda, Shinya Shimoyama, Takumi Taniguchi, Tadashi Kaneko, Takuya Hayashi, Kenji Kubo, Toshiaki Iba, Yutaka Umemura, Chihiro Narita, Tadashi Nagato, Hiroomi Tatsumi, Takeshi Yoshida, Satoshi Suzuki, Isao Nahara, Takashi Tagami, Akihito Tampo, Tatsuya Kawasaki, Kensuke Nakamura, Shuhei Takauji, Shin Nunomiya, Yujiro Matsuishi, Yusuke Tsutsumi, Kent Doi, Katsuhiko Hashimoto, Norihiro Nishioka, Shigeki Kushimoto, Keita Kanehata, Naoki Higashibeppu, Kohkichi Andoh, Go Ishimaru, Nozomi Takahashi, Takeshi Umegaki, Isao Nagata, Ryosuke Tsuruta, Keisuke Minami, Yoko Takahashi, Hirotaka Furusono, Yusuke Kawai, Naoya Iguchi, Takero Terayama, Hisashi Imahase, Akira Ouchi, Hiroshi Tanaka, Yoshihiro Tomioka, Motohiro Sekino, Yoshihiro Hagiwara, Takayuki Ogura, Hiraku Funakoshi, Tomoya Hirose, Hiroshi Okuda, Morihiro Katsura, Takeshi Wada, Shinya Miura, Sho Takahashi, Yu Inata, Sei Takahashi, Shigeaki Inoue, Hiroyuki Yamada, Takeshi Suzuki, Kiyoyasu Kurahashi, Yoshitaka Aoki, Yuki Nakamori, Moritoki Egi, Toshiaki Hamasaki, Minoru Hayashi, Naoki Hara, Ichiro Nagasawa, Naoyuki Fujimura, Shunsuke Taito, Tetsuro Nishimura, Shodai Yoshihiro, Yoshifumi Ohchi, Yu Onodera, Tomohiro Suhara, Machi Yanai, Naoyuki Matsuda, Masayuki Ozaki, Yohei Okada, Takeshi Hatachi, Tomohisa Shoko, Naohisa Masunaga, Masahiro Kashiura, Yoshitaka Hara, Ryoichi Miyashita, Matsuyuki Doi, Kentaro Tokunaga, Kenta Ito, Akihiro Kanaya, Eisuke Kako, Taichiro Tsunoyama, Tadashi Ishihara, Makoto Aoki, Nobuaki Shime, Tatsuma Fukuda, Kohei Ota, Kei Hayashida, Ken ichi Kano, Masahito Sakai, Takashi Irinoda, Taka-aki Nakada, Atsushi Kawaguchi, Takakuni Abe, Manabu Shimoto, Yuki Iida, Takahiro Kido, Tetsuya Sato, Yusuke Minematsu, Kohei Takashima, Yusuke Ito, Shinichiro Ohshimo, and Hideto Yasuda
- Subjects
medicine.medical_specialty ,Weakness ,Acute medicine ,Guideline ,Critical Care and Intensive Care Medicine ,Sepsis ,sepsis ,systematic review ,Multidisciplinary approach ,Medicine ,guidelines ,Intensive care medicine ,Treatment system ,evidence‐based medicine ,RC86-88.9 ,business.industry ,Septic shock ,General Engineering ,Medical emergencies. Critical care. Intensive care. First aid ,Evidence-based medicine ,medicine.disease ,Clinical Practice ,GRADE ,septic shock ,medicine.symptom ,business ,evidence-based medicine - Abstract
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis and septic shock created as revised from J-SSCG 2016 jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in September 2020 and published in February 2021. An English-language version of these guidelines was created based on the contents of the original Japanese-language version. The purpose of this guideline is to assist medical staff in making appropriate decisions to improve the prognosis of patients undergoing treatment for sepsis and septic shock. We aimed to provide high-quality guidelines that are easy to use and understand for specialists, general clinicians, and multidisciplinary medical professionals. J-SSCG 2016 took up new subjects that were not present in SSCG 2016 (e.g., ICU-acquired weakness [ICU-AW], post-intensive care syndrome [PICS], and body temperature management). The J-SSCG 2020 covered a total of 22 areas with four additional new areas (patient- and family-centered care, sepsis treatment system, neuro-intensive treatment, and stress ulcers). A total of 118 important clinical issues (clinical questions, CQs) were extracted regardless of the presence or absence of evidence. These CQs also include those that have been given particular focus within Japan. This is a large-scale guideline covering multiple fields; thus, in addition to the 25 committee members, we had the participation and support of a total of 226 members who are professionals (physicians, nurses, physiotherapists, clinical engineers, and pharmacists) and medical workers with a history of sepsis or critical illness. The GRADE method was adopted for making recommendations, and the modified Delphi method was used to determine recommendations by voting from all committee members.As a result, 79 GRADE-based recommendations, 5 Good Practice Statements (GPS), 18 expert consensuses, 27 answers to background questions (BQs), and summaries of definitions and diagnosis of sepsis were created as responses to 118 CQs. We also incorporated visual information for each CQ according to the time course of treatment, and we will also distribute this as an app. The J-SSCG 2020 is expected to be widely used as a useful bedside guideline in the field of sepsis treatment both in Japan and overseas involving multiple disciplines., other authors: Satoru Hashimoto,Daisuke Hasegawa,Junji Hatakeyama,Naoki Hara,Naoki Higashibeppu,Nana Furushima,Hirotaka Furusono,Yujiro Matsuishi,Tasuku Matsuyama,Yusuke Minematsu,Ryoichi Miyashita,Yuji Miyatake,Megumi Moriyasu,Toru Yamada,Hiroyuki Yamada,Ryo Yamamoto,Takeshi Yoshida,Yuhei Yoshida,Jumpei Yoshimura,Ryuichi Yotsumoto,Hiroshi Yonekura,Takeshi Wada,Eizo Watanabe,Makoto Aoki,Hideki Asai,Takakuni Abe,Yutaka Igarashi,Naoya Iguchi,Masami Ishikawa,Go Ishimaru,Shutaro Isokawa,Ryuta Itakura,Hisashi Imahase,Haruki Imura,Takashi Irinoda,Kenji Uehara,Noritaka Ushio,Takeshi Umegaki,Yuko Egawa,Yuki Enomoto,Kohei Ota,Yoshifumi Ohchi,Takanori Ohno,Hiroyuki Ohbe,Kazuyuki Oka,Nobunaga Okada,Yohei Okada,Hiromu Okano,Jun Okamoto,Hiroshi Okuda,Takayuki Ogura,Yu Onodera,Yuhta Oyama,Motoshi Kainuma,Eisuke Kako,Masahiro Kashiura,Hiromi Kato,Akihiro Kanaya,Tadashi Kaneko,Keita Kanehata,Ken-ichi Kano,Hiroyuki Kawano,Kazuya Kikutani,Hitoshi Kikuchi,Takahiro Kido,Sho Kimura,Hiroyuki Koami,Daisuke Kobashi,Iwao Saiki,Masahito Sakai,Ayaka Sakamoto,Tetsuya Sato,Yasuhiro Shiga,Manabu Shimoto,Shinya Shimoyama,Tomohisa Shoko,Yoh Sugawara,Atsunori Sugita,Satoshi Suzuki,Yuji Suzuki,Tomohiro Suhara,Kenji Sonota,Shuhei Takauji,Kohei Takashima,Sho Takahashi,Yoko Takahashi,Jun Takeshita,Yuuki Tanaka,Akihito Tampo,Taichiro Tsunoyama,Kenichi Tetsuhara,Kentaro Tokunaga,Yoshihiro Tomioka,Kentaro Tomita,Naoki Tominaga,Mitsunobu Toyosaki,Yukitoshi Toyoda,Hiromichi Naito,Isao Nagata,Tadashi Nagato,Yoshimi Nakamura,Yuki Nakamori,Isao Nahara,Hiromu Naraba,Chihiro Narita,Norihiro Nishioka,Tomoya Nishimura,Kei Nishiyama,Tomohisa Nomura,Taiki Haga,Yoshihiro Hagiwara,Katsuhiko Hashimoto,Takeshi Hatachi,Toshiaki Hamasaki,Takuya Hayashi,Minoru Hayashi,Atsuki Hayamizu,Go Haraguchi,Yohei Hirano,Ryo Fujii,Motoki Fujita,Naoyuki Fujimura,Hiraku Funakoshi,Masahito Horiguchi,Jun Maki,Naohisa Masunaga,Yosuke Matsumura,Takuya Mayumi,Keisuke Minami,Yuya Miyazaki,Kazuyuki Miyamoto,Teppei Murata,Machi Yanai,Takao Yano,Kohei Yamada,Naoki Yamada,Tomonori Yamamoto,Shodai Yoshihiro,Hiroshi Tanaka,Osamu Nishida, Guidelines
- Published
- 2021
- Full Text
- View/download PDF
9. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events
- Author
-
Yuji Moritou, Kazuyuki Ikeda, Norihisa Horita, Eisuke Suganuma, Shouzaburoh Doi, Shinya Shimoyama, Tsutomu Saji, Kiyoshi Nagumo, Masahide Kaneko, Hiroshi Masuda, Seiichi Sato, Satoru Iwashima, Takafumi Honda, Kenji Furuno, Shinichi Matsuda, Yohei Akazawa, Yoshihide Mitani, Kenichiro Yamamura, Hitoshi Kato, Shigeto Fuse, Masaru Miura, Hiroyuki Yamagishi, Tomoyuki Miyamoto, Makoto Watanabe, Yasunobu Hayabuchi, Yoichi Kawamura, Miyuki Hayashi, Junko Shiono, Masako Tomotsune, Kenichi Watanabe, Shinichi Takatsuki, Atushi Kitagawa, Yuichi Nomura, Hiroshi Suzuki, Yoshi Fukasawa, Kentaro Aso, Masaru Terai, Manatomo Toyono, Eiki Nishihara, Tetsuya Sano, Kenji Suda, Kenichi Okumura, Noriko Motoki, Kenji Kuraishi, Masahiro Kamada, Shohei Ogata, Tsutomu Takahashi, Makiko Yoshida, Masaki Yamamoto, Keiichi Hirono, Ryuji Fukazawa, Hiroshi Katyama, Kenji Hamaoka, Daisuke Omori, Tohru Kobayashi, Masahiro Ishii, Hiroyuki Ohashi, Akiko Komori, Tsuneyuki Nakamura, Jun Maeda, Kenji Waki, Tetsuji Kaneko, Satoshi Matsuzaki, Aya Ozeki, Sayaka Mii, Taichi Kato, Mamoru Ayusawa, Naoya Fukushima, and Atsuhito Takeda
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,Drug Resistance ,Coronary Disease ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Standard score ,Mucocutaneous Lymph Node Syndrome ,Coronary Angiography ,Risk Assessment ,Severity of Illness Index ,03 medical and health sciences ,0302 clinical medicine ,Sex Factors ,Japan ,Risk Factors ,030225 pediatrics ,Internal medicine ,Severity of illness ,medicine ,Humans ,Child ,Survival rate ,Retrospective Studies ,Original Investigation ,business.industry ,Coronary Aneurysm ,Immunoglobulins, Intravenous ,Infant ,Retrospective cohort study ,medicine.disease ,Thrombosis ,Stenosis ,medicine.anatomical_structure ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Kawasaki disease ,Female ,business ,Artery - Abstract
IMPORTANCE: Few studies with sufficient statistical power have shown the association of the z score of the coronary arterial internal diameter with coronary events (CE) in patients with Kawasaki disease (KD) with coronary artery aneurysms (CAA). OBJECTIVE: To clarify the association of the z score with time-dependent CE occurrence in patients with KD with CAA. DESIGN, SETTING, AND PARTICIPANTS: This multicenter, collaborative retrospective cohort study of 44 participating institutions included 1006 patients with KD younger than 19 years who received a coronary angiography between 1992 and 2011. MAIN OUTCOMES AND MEASURES: The time-dependent occurrence of CE, including thrombosis, stenosis, obstruction, acute ischemic events, and coronary interventions, was analyzed for small (z score
- Published
- 2018
10. Usefulness of Percutaneous Transluminal Pulmonary Artery Balloon Angioplasty after Bilateral Pulmonary Artery Banding: Prevention against Additional Surgical Interventions
- Author
-
Takashi Miyamoto, Kimiko Nakajima, Kensuke Tanaka, Kentaro Ikeda, Shinya Shimoyama, Yoichiro Ishii, Hirokazu Arakawa, Tomio Kobayashi, and Mitsuru Seki
- Subjects
medicine.medical_specialty ,Interventional cardiology ,business.industry ,medicine.medical_treatment ,Balloon catheter ,Balloon ,medicine.disease ,Pulmonary artery banding ,Surgery ,Hypoplastic left heart syndrome ,medicine.anatomical_structure ,Internal medicine ,medicine.artery ,Ductus arteriosus ,Angioplasty ,Pulmonary artery ,medicine ,Cardiology ,business - Abstract
Objectives: We evaluated the efficacy of balloon dilatation after bilateral pulmonary artery banding for the treatment of severe congenital heart disease that depends on patent ductus arteriosus for systemic circulation. Background: Neonatal cardiopulmonary bypass can cause brain injury, which may result in a severely impaired neurodevelopmental outcome. Hence, we perform bilateral pulmonary artery banding combined with postoperative percutaneous trans catheter angioplasty with balloon dilatation as first-stage palliation. Methods: From October 2007 to December 2013, 27 consecutive patients underwent bilateral pulmonary artery banding at our institution. We retrospectively obtained their diagnostic, clinical, and catheter examination data from the medical records. Results: Bilateral pulmonary artery banding was performed at a median of 7 days. Among the 27 patients, 16 underwent expansive angioplasty using a balloon catheter at each banding site to increase pulmonary blood flow. The mean age at dilatation was 53.4 ± 25.9 days, and the mean pulmonary artery index significantly increased from 130.6 mm2/m2 ± 51.1 mm2/m2 before dilatation to 243.6 mm2/ m2 ± 93.5 mm2/m2 after dilatation (p
- Published
- 2017
- Full Text
- View/download PDF
11. Abstract 13850: Severity Assessment of Coronary Artery Aneurysm by Z-score of the Internal Diameter in Kawasaki Disease
- Author
-
Keiichi Hirono, Tetsuji Kaneko, Taichi Kato, Ryuji Fukazawa, Masaru Miura, Kenji Suda, Yuichi Nomura, Shinya Shimoyama, Shigeto Fuse, Kenji Waki, Kenji Hamaoka, Hitoshi Kato, Hiroyuki Yamagishi, Tsutomu Saji, Naoya Fukushima, and Tohru Kobayashi
- Subjects
Coronary artery aneurysm ,Body surface area ,medicine.medical_specialty ,business.industry ,Hazard ratio ,medicine.disease ,Thrombosis ,Aneurysm ,Physiology (medical) ,Internal medicine ,Right coronary artery ,medicine.artery ,medicine ,Cardiology ,Kawasaki disease ,cardiovascular diseases ,Cardiology and Cardiovascular Medicine ,business ,Survival rate - Abstract
Introduction: The severity of coronary artery aneurysms (CAA) in patients with Kawasaki disease (KD) has been recently classified according to the z-score. However, it is not known whether this classification can predict coronary events such as stenosis, obstruction, and thrombosis. Methods: In this multicenter retrospective study, data on height, weight, CAA diameter measured by echocardiography in the acute phase, and the clinical course in KD patients 18 years of age or younger who received a coronary angiography between 1992 and 2011 were collected. Time-dependent occurrence of coronary events was analyzed by Kaplan-Meier method according to small (z-score, < 5.0), medium (≥ 5.0 to < 10.0), and large (≥ 10.0) CAA using a 5 increment scale scheduled to be included in the new American Heart Association criteria. Cox regression analysis was used to identify risk factors for coronary events. The occurrence rate of major cardiac events such as angina pectoris, myocardial infarction, and cardiac death was also analyzed. Results: Data were analyzed for 1,002 patients from 44 institutions. Both the body surface area and CAA diameters were available in 741 cases for the right coronary artery (RCA) and 609 cases for the left anterior descending artery (LAD). Coronary events occurred in 83 (11.2%) of the RCA group and 57 (9.4%) of the LAD group, while major events occurred in 30 cases (3.0%). The 10-year event-free survival rate for coronary events for small, medium, and large aneurysms was 100, 95.5, and 64.9% in the RCA group, and 100, 94.4, and 63.5% for aneurysms in the LAD group, respectively. The rate of major cardiac events was 98.5, 98.1, and 87.6% for the RCA group, and 100, 97.5, and 86.8% for the LAD group, respectively. Cox regression analyses showed that the z-score of the CAA diameter was an independent risk factor for coronary events for the RCA [large versus medium aneurysm; hazard ratio (HR) 2.8, 95% confidence interval (CI) 1.5 to 5.3, p = 0.002] and the LAD [HR 3.2, 95% CI 1.6 to 6.5, p = 0.015] groups. Conclusions: The severity assessment of CAA using the 5-increment z-score for coronary arterial diameter can predict the time-dependent occurrence of coronary events in patients with KD.
- Published
- 2015
- Full Text
- View/download PDF
12. A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population
- Author
-
Tohru Kobayashi, Shigeto Fuse, Naoko Sakamoto, Masashi Mikami, Shunichi Ogawa, Kenji Hamaoka, Yoshio Arakaki, Tsuneyuki Nakamura, Hiroyuki Nagasawa, Taichi Kato, Toshiaki Jibiki, Satoru Iwashima, Masaru Yamakawa, Takashi Ohkubo, Shinya Shimoyama, Kentaro Aso, Seiichi Sato, Tsutomu Saji, Hitoshi Kato, Chisato Akita, Takashi Kuwahara, Takahiro Suzuki, Takamichi Ishikawa, Masayuki Watanabe, Mitsuru Seki, Kentaro Ikeda, Yoichiro Ishii, Tomio Kobayashi, Etsuko Hasegawa, Hiromi Shiraiwa, Kyoko Hayashi, Chisato Tabata, Motoki Miyauchi, Junko Miyamoto, Michiko Wada, Hisashi Takasugi, Masaki Yamamoto, Katsuhiko Yamada, Satoshi Hasegawa, Shinya Tsukano, Sayaka Ozawa, Yoshiko Ohnuma, Fukiko Ichida, Seiji Kawamura, Eisuke Suganuma, Shinichi Matsuda, Kaori Sekine, Satoshi Kondo, Masaru Miura, Toshiko Kobayashi, Naoya Fukushima, Tomomi Kure, Yuichi Nomura, Daisuke Eguchi, Nobuyuki Katsumata, Masako Fujiwara, Kota Nakamura, Kenji Furuno, Itsumi Hirasawa, Midori Miki, Takashi Kanai, Hiroyoshi Yoshimoto, Yoshiyuki Kudo, Rumi Yamakawa, Kenji Suda, Keiji Haseyama, Hiromi Manabe, Hiroki Kajino, Kiminori Masuda, Kenji Yasuda, Masayuki Teraguchi, Sachiko Sasaki, Yukie Kamura, Kotaro Oyama, Tetsuya Sano, Kota Takei, Takuo Furukawa, Michihiko Ueno, Takanari Fujii, Hiromi Muta, Mitsunori Nishiyama, and Shozaburo Doi
- Subjects
Male ,Aging ,medicine.medical_specialty ,Adolescent ,030204 cardiovascular system & hematology ,Anterior Descending Coronary Artery ,Standard score ,Pediatrics ,Sensitivity and Specificity ,Normal distribution ,03 medical and health sciences ,Imaging, Three-Dimensional ,0302 clinical medicine ,Japan ,Goodness of fit ,Reference Values ,Bayesian information criterion ,Internal medicine ,medicine ,Humans ,Computer Simulation ,Radiology, Nuclear Medicine and imaging ,030212 general & internal medicine ,Child ,Body surface area ,Sex Characteristics ,Models, Statistical ,business.industry ,Infant, Newborn ,Models, Cardiovascular ,Infant ,Reproducibility of Results ,Regression analysis ,Coronary Vessels ,Data set ,Echocardiography ,Child, Preschool ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Algorithms - Abstract
Background Several coronary artery Z score models have been developed. However, a Z score model derived by the lambda-mu-sigma (LMS) method has not been established. Methods Echocardiographic measurements of the proximal right coronary artery, left main coronary artery, proximal left anterior descending coronary artery, and proximal left circumflex artery were prospectively collected in 3,851 healthy children ≤18 years of age and divided into developmental and validation data sets. In the developmental data set, smooth curves were fitted for each coronary artery using linear, logarithmic, square-root, and LMS methods for both sexes. The relative goodness of fit of these models was compared using the Bayesian information criterion. The best-fitting model was tested for reproducibility using the validation data set. The goodness of fit of the selected model was visually compared with that of the previously reported regression models using a Q-Q plot. Results Because the internal diameter of each coronary artery was not similar between sexes, sex-specific Z score models were developed. The LMS model with body surface area as the independent variable showed the best goodness of fit; therefore, the internal diameter of each coronary artery was transformed into a sex-specific Z score on the basis of body surface area using the LMS method. In the validation data set, a Q-Q plot of each model indicated that the distribution of Z scores in the LMS models was closer to the normal distribution compared with previously reported regression models. Finally, the final models for each coronary artery in both sexes were developed using the developmental and validation data sets. A Microsoft Excel–based Z score calculator was also created, which is freely available online (http://raise.umin.jp/zsp/calculator/). Conclusions Novel LMS models with which to estimate the sex-specific Z score of each internal coronary artery diameter were generated and validated using a large pediatric population.
- Published
- 2016
- Full Text
- View/download PDF
13. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease
- Author
-
Kentaro Ikeda, Shinya Shimoyama, Kimiko Nakajima, Mitsuru Seki, Naoko Sakamoto, Tomio Kobayashi, Akihiro Morikawa, Tohru Kobayashi, Takahiro Suzuki, Yoichiro Ishii, and Hirokazu Arakawa
- Subjects
Male ,medicine.medical_specialty ,Prednisolone ,Drug Resistance ,Mucocutaneous Lymph Node Syndrome ,law.invention ,Randomized controlled trial ,Rescue therapy ,law ,hemic and lymphatic diseases ,Internal medicine ,medicine ,Humans ,Glucocorticoids ,Retrospective Studies ,Framingham Risk Score ,biology ,business.industry ,C-reactive protein ,Immunoglobulins, Intravenous ,medicine.disease ,Surgery ,Methylprednisolone ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Acute Disease ,biology.protein ,Kawasaki disease ,Drug Therapy, Combination ,Female ,Antibody ,business ,medicine.drug - Abstract
Objectives To determine the most effective first-line rescue therapy for intravenous immunoglobulin (IVIG) nonresponders, using IVIG, prednisolone, or both, to prevent coronary artery abnormalities (CAAs). Study design We retrospectively reviewed the clinical records of 359 consecutive patients with Kawasaki disease who failed to respond to initial IVIG. Results CAAs up to 1 month after treatment were less common in the IVIG+prednisolone group (15.9%) than in the IVIG group (28.7%, P = .005) and the prednisolone group (30.6%, P = .01). The IVIG+prednisolone group had significantly lower risks of failing to respond to first-line rescue therapy (aOR 0.16, 95% CI 0.09-0.31), CAAs up to 1 month (aOR 0.46, 95% CI 0.27-0.90), and CAAs at 1 month (aOR 0.40, 95% CI 0.18-0.91) than the IVIG group. In the prednisolone and IVIG+prednisolone groups, risk score, day of illness at first-line rescue therapy, prednisolone monotherapy, and resistance to first-line rescue therapy were independent risk factors for CAA. Sex and resistance to first-line rescue therapy were independent risk factors in the IVIG group. Conclusions IVIG+prednisolone may be superior to IVIG or prednisolone as first-line rescue therapy in the treatment of IVIG nonresponders. To establish the efficacy of rescue therapy with IVIG+prednisolone following nonresponse to initial IVIG, a prospective randomized trial is warranted.
- Published
- 2012
14. External validation of a risk score to predict intravenous immunoglobulin resistance in patients with kawasaki disease
- Author
-
Mitsuru Seki, Kazuo Takeuchi, Takahiro Suzuki, Tetsuya Otani, Shinya Shimoyama, Tomio Kobayashi, Keiji Tsuchiya, Mamoru Ayusawa, Yoichiro Ishii, Kentaro Ikeda, Kenji Yasuda, Tohru Kobayashi, Hirokazu Arakawa, and Akihiro Morikawa
- Subjects
Microbiology (medical) ,Male ,medicine.medical_specialty ,Systemic disease ,Mucocutaneous Lymph Node Syndrome ,Gastroenterology ,Japan ,hemic and lymphatic diseases ,Immunopathology ,Internal medicine ,medicine ,Humans ,Risk factor ,Child ,Infusions, Intravenous ,Autoimmune disease ,Framingham Risk Score ,Vascular disease ,business.industry ,Immunoglobulins, Intravenous ,Infant ,medicine.disease ,Prognosis ,Surgery ,Infectious Diseases ,Treatment Outcome ,ROC Curve ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Kawasaki disease ,Female ,Vasculitis ,business - Abstract
we previously developed a new risk score to predict intravenous immunoglobulin (IVIG) resistance in Kawasaki disease. However, the IVIG dosage used in that study (1 g/kg/d for 2 consecutive days) differs from the single infusion of 2 g/kg recommended in the United States and elsewhere. Our aim was to assess the validity and applicability of our risk score in patients treated with a single infusion.we used a database of 1626 patients with Kawasaki disease given initial IVIG treatment at a dose of 1 g/kg/d for 2 consecutive days (n = 990; IVIG- 1 g/kg × 2) or 2 g/kg/d for 1 day (n = 636; IVIG- 2 g/kg × 1) across 17 hospitals in Japan. Patients received the total IVIG dose within 36 hours in IVIG- 1 g/kg × 2 and 24 hours in IVIG- 2 g/kg × 1. We stratified the patients according to a risk scoring system developed to predict IVIG unresponsiveness, based on scores of ≥ 5 points. We compared the accuracy of prediction between the 2 groups using receiver operating characteristic analysis.baseline characteristics and clinical outcomes were similar between both groups. The areas under the receiver operating characteristic curve in IVIG- 2 g/kg × 1 were similar to those of IVIG- 1 g/kg × 2. Using a cut-off risk score of ≥ 5 points, we could identify IVIG resistance in terms of coronary artery abnormalities within 1 month and coronary artery abnormalities at 1 month with equivalent sensitivity and specificity in both groups.our risk score can be used to predict IVIG unresponsiveness to a regimen based on a single infusion of 2 g/kg IVIG.
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.